Sensus Healthcare, Inc. (SRTS) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$3.12

From 52W high−42.45%

Volume51055.00

Market cap$50.21M

P/E (TTM)—

P/S (TTM)2.9x

Div yield—

Key dataSep 18, 2026

Open

$3.12

From 52W high

−42.45%

Volume

51055.00

Market cap

$50.21M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.7x

P/E (TTM)

—

RSI (14)

47.2

MomentumView details →

1D Return

−2.24%

YTD Return

−21.61%

SummaryUpdated Jun 1, 2026

Sensus Healthcare, Inc. (NASDAQ:SRTS) is a medical device company founded in 2010 and headquartered in Boca Raton, Florida. The company went public in July 2016 and specializes in manufacturing and selling radiation therapy devices to healthcare providers worldwide. Sensus has established itself as a leader in superficial radiation therapy technology, with over 880 systems installed globally and a growing international presence across multiple continents.

Ask drillr about Sensus Healthcare, Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−3.7x

EV/Sales

2.0x

P/S (TTM)

2.9x

P/B (TTM)

1.4x

ProfitabilityView details →

Gross Margin

36.39%

Net Margin

−88.45%

EBITDA Margin

−54.26%

ROE (TTM)

−42.01%

ROA (TTM)

−37.53%

Asset Turnover

0.38x

GrowthView details →

Revenue YoY

−53.39%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−14.86%

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−2.24%

YTD Return

−21.61%

1Y Return

+0.32%

RSI (14)

47.2

vs 50D SMA

+0.35%

vs 200D SMA

−15.97%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

8.71x

Quick Ratio

4.44x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.53

EPS Surprise

−324.00%

Beats (12Q)

5/12

Next Q EPS Est

−$0.06

Avg Surprise (4Q)

−138.00%

Rev Surprise

−49.99%

Financials snapshotView financials →

Revenue (TTM)

17.51M

Net Income (TTM)

−15.48M

Op. CF (TTM)

−6.80M

Next earningsNov 5, 2026 →

Latest newsMore news →

Sensus Healthcare reported second quarter 2026 financial results with revenues of $2.3 million, a decrease of $5.0 million from the same quarter in 2025.38d ago

Sensus Healthcare, Inc. entered into a $15 million revolving credit facility with City National Bank of Florida, secured by restricted cash collateral and a first-priority security interest in its assets.108d ago

Similar companies

Spectral AI, Inc.MDAI Inspira Technologies Oxy B.H.N. Ltd.IINN Envoy Medical, Inc.COCH TELA Bio, Inc.TELA Rapid Micro Biosystems, Inc.RPID Baird Medical Investment Holdings LimitedBDMD Find similar companies →

Latest newsMore news →

Sensus Healthcare reported second quarter 2026 financial results with revenues of $2.3 million, a decrease of $5.0 million from the same quarter in 2025.38d ago Sensus Healthcare, Inc. entered into a $15 million revolving credit facility with City National Bank of Florida, secured by restricted cash collateral and a first-priority security interest in its assets.108d ago